Overactive Bladder Drug Gains Pediatric Indication

(MedPage Today) -- The beta-3 adrenergic agonist mirabegron (Myrbetriq) gained an indication for neurogenic detrusor overactivity (NDO), a form of bladder dysfunction, in children 3 and older, the FDA announced Thursday. The drug will be available...